about
Human malarial disease: a consequence of inflammatory cytokine releaseA novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignmentAlternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factorDual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cellsAlpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon modelMolecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signalingHuman CAP18: a novel antimicrobial lipopolysaccharide-binding proteinRole of IL-12 in Staphylococcus aureus-triggered arthritis and sepsisBench-to-bedside review: sepsis is a disease of the microcirculation.Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgerySevere traumatic head injury affects systemic cytokine expressionDiagnosis-dependent relationships between cytokine levels and survival in patients admitted for surgical critical careThe physico-chemical characteristics of the phosphocholine-containing glycoglycerolipid MfGL-II govern the permeability properties of Mycoplasma fermentans.Lipopolysaccharide-inducible gene expression profile in human monocytes.Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine.Growth of very low birth weight infants fed with milk from a human milk bank selected according to the caloric and protein value.Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.Legionella pneumophila growth restriction in permissive macrophages cocultured with nonpermissive lipopolysaccharide-activated macrophagesCovalent polymyxin B conjugate with human immunoglobulin G as an antiendotoxin reagent.Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model.Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitorAntibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trialMicrocirculatory dysfunction in sepsis: a pathogenetic basis for therapy?Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome.Prophylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model.Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation.Repeated oronasal exposure to lipopolysaccharide induced mucosal IgA responses in periparturient dairy cowsAltered pharmacokinetics of ceftazidime in critically ill patients.High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortalityRest energy expenditure is decreased during the acute as compared to the recovery phase of sepsis in newborns.Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat modelNew antiseptic peptides to protect against endotoxin-mediated shock.Potential therapeutic role of cationic peptides in three experimental models of septic shock.Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells.The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase.
P2860
Q21034098-9009EB36-F7CA-4832-B6B7-F9A66565A4B5Q22009378-D220B7F8-1EF7-4214-8737-979FA2CBF278Q24306941-DD35DD57-1ACB-425D-998C-8C088105A5A6Q24514488-7C9E2F81-454D-451C-8F1B-860B83F8C792Q24656054-84388D58-C761-4C4C-ADA2-E91C61B7A04FQ24675633-FF64890C-9F69-4094-8D84-50DB948AAD83Q24682905-F81BF1DA-2F9B-4E54-98A8-C0697CE4BEC1Q24792859-37513243-22DA-43F5-B22E-AE4B48E52B72Q24800640-0B11BFE6-4169-4015-91FF-B6F3075D2936Q28293840-0A973E26-D740-41CB-B5A9-B1D8C144313EQ30421596-7239C5A8-FD83-4BA1-95C9-EFE3F351EF1BQ30432507-FEF1572D-A7CD-48E6-B877-DCA1FFE6DB4CQ30655354-9668219F-304F-41AD-A3DF-C57C3D606189Q33195040-BFA58B3E-E107-42F4-855C-3ED0EC19E2B4Q33356537-A1C641E0-4837-480D-A788-F612FFDAB305Q33452932-5C4EBFBE-1A8A-44DF-94A7-11B825AB3700Q33535029-5F653D1F-665B-458C-97E5-839BB5BDE890Q33616396-6435DE97-6777-40AF-B42B-97CBB9228FEEQ33691053-1CA10BAC-C24B-449D-83BA-B229D559EE68Q33703812-B72BF90F-2D8E-427D-98C5-31A9F38708E5Q33754022-2290E9C9-0D9F-4F93-91B7-A4A56474EAF7Q33754239-1CF8D409-D852-46B0-9C2B-C3F311C45653Q33794000-FAAA8499-3133-4BCF-9925-595A20F5105CQ33796490-83C077CC-E0F1-4956-B0B5-6D9D50023049Q33843589-7C16550A-2165-46BF-8769-851C38D608E3Q33885948-C75368DF-0EB4-4D2B-93A5-D6735250F168Q33892692-EF6568B4-9BAF-4AB3-A6DB-3C072D3B960CQ33894207-AC8E673A-9652-4110-93F1-8AD849ACB1C4Q33895675-42F1CAC1-17E0-4487-9E5F-8AE6ABE435F1Q33952563-BCEACBC2-46D2-4A10-9370-E69A642D233AQ33977268-1749E172-B8F2-411A-B6ED-A29F25BF4254Q33983134-06A04497-E2E1-4378-841E-4E7B4A95FA74Q34005092-DB4B72B9-75B0-4931-B342-D9EE905251EAQ34006691-82C7E107-BC7D-4F4C-82E9-860417E29AECQ34068677-E06D28E2-2AA4-4672-9678-1029D6972087Q34104726-7119011A-8746-4DCC-BC08-5116A9C9C733Q34108514-19244108-551D-40C7-801A-4E6B08B16B27Q34109677-99469340-FEFE-4685-B988-39B699E65523Q34120641-2175594A-0B77-4706-A52D-961C1F643A53Q34133429-8A9E8879-84EC-4987-ACF1-BB3B4E32E04A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on September 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
The pathogenesis of sepsis.
@en
The pathogenesis of sepsis.
@nl
type
label
The pathogenesis of sepsis.
@en
The pathogenesis of sepsis.
@nl
prefLabel
The pathogenesis of sepsis.
@en
The pathogenesis of sepsis.
@nl
P1476
The pathogenesis of sepsis.
@en
P2093
P304
P356
10.7326/0003-4819-115-6-457
P407
P577
1991-09-01T00:00:00Z